Core Viewpoint - The company has developed an AI platform for drug research that enhances the precision and efficiency of drug development processes [2] Group 1: AI Platform - The AI platform, referred to as the "Smart Drug AI Platform," is capable of predicting toxicity, activity, and drug-likeness [2] - This platform aims to improve the accuracy and efficiency of drug development [2] Group 2: New Drug Department - The new drug department utilizes an organoid platform that offers drug screening, efficacy evaluation, and safety assessment services [2] - These services are designed to support more precise and efficient drug research [2]

Core Viewpoint - The company is currently not involved in the brain-computer interface sector but will closely monitor developments in this industry [1] Group 1: AI Technology in Drug Development - The company utilizes AI technology in its innovative drug research, specifically in AIDD (Artificial Intelligence Drug Discovery) and CADD (Computer-Aided Drug Design) [1] - The company has developed its own AI platform, known as the Smart Drug AI platform, which can be applied to toxicity prediction as well as activity and drug-likeness prediction [1] Group 2: Organoid Platform and Drug Development Services - The company's organoid platform provides drug development technical services, including drug screening, efficacy evaluation, and safety assessment [1] - This platform aims to enhance the precision and efficiency of drug development processes [1]

Core Viewpoint - The company, Baicheng Pharmaceutical (301096.SZ), is currently not involved in the brain-computer interface sector but will closely monitor developments in this industry [1] Group 1: AI Technology Utilization - The company applies AI technology in innovative drug research, specifically in AIDD (Artificial Intelligence Drug Discovery) and CADD (Computer-Aided Drug Design) [1] - The company has developed its own AI platform, known as the Smart Drug AI platform, which is utilized for toxicity prediction as well as activity and drug-likeness prediction [1] Group 2: Organoid Platform - The company possesses an organoid platform that provides drug development technical services, including drug screening, efficacy evaluation, and safety assessment [1] - This platform aims to enhance the precision and efficiency of drug development processes [1]

Core Viewpoint - The company, Baicheng Pharmaceutical, positions itself as a technology-driven pharmaceutical research and development enterprise, emphasizing innovation and a comprehensive value chain [1] Group 1: Company Overview - Baicheng Pharmaceutical is characterized by its innovative, full-value chain, platform-based, and inclusive attributes [1] - The company has developed an AI platform named "Smart Drug AI," which is applicable for toxicity prediction as well as activity and drug-likeness prediction [1] Group 2: Research and Development Capabilities - The new drug department of the company features an organoid platform that offers drug development technical services, including drug screening, efficacy evaluation, and safety assessment [1]

Core Viewpoint - Baicheng Pharmaceutical (301096.SZ) is a technology-driven pharmaceutical research and development company that integrates innovative, full-value chain, platform-based, and collaborative attributes [1] Group 1 - The company has developed an AI platform called "Smart Drug AI," which can be applied to toxicity prediction as well as activity and drug-likeness prediction [1] - The new drug department features an organoid platform that provides drug research and development technical services, including drug screening, efficacy evaluation, and safety assessment [1]

Core Viewpoint - Baicheng Pharmaceutical (301096.SZ) is positioned as an innovative pharmaceutical research and development company that integrates technology development with a full value chain and platform-based attributes [2] Group 1: Company Overview - The company focuses on technology development as its core competency [2] - It operates as a comprehensive pharmaceutical R&D enterprise with innovative and collaborative characteristics [2] Group 2: Product and Services - Baicheng Pharmaceutical has developed an AI platform named "Smart Drug AI," which is applicable for toxicity prediction as well as activity and drug-likeness prediction [2] - The new drug department features an organoid platform that offers drug screening, efficacy evaluation, and safety assessment services [2]